Get the Stockscreener App
0.0515
12.71%
-0.0075
After Hours:
.03
-0.0215
-41.75%
Oncotelic Therapeutics Inc Stock (OTLC) Forecast
The Oncotelic Therapeutics Inc (OTLC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.2176, representing a +322.59% increase from the current price of $0.0515. The highest analyst price target is $0.2231, and the lowest is $0.2122.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OTLC Price Target
Average 0.256
(+397.15% Upside)
Long-term OTLC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oncotelic Therapeutics Inc financial reports and earnings history, Oncotelic Therapeutics Inc (OTLC) stock could reach $0.7266 by 2030, $2.1917 by 2040 and $1.9378 by 2050. See the projected annual prices until 2050 of the Oncotelic Therapeutics Inc stock below:
- Oncotelic Therapeutics Inc (OTLC) is expected to reach an average price of $1.2885 in 2035, with a high prediction of $1.4297 and a low estimate of $1.2885. This indicates an $2,402% rise from the last recorded price of $0.0515.
- Oncotelic Therapeutics Inc (OTLC) stock is projected to chart a bullish course in 2040, with an average price target of $1.9986, representing an $3,781% surge from its current level. The forecast ranges from a conservative $1.9993 to a sky-high $2.1917.
- Our analysts predict Oncotelic Therapeutics Inc (OTLC) to jump 5,357% by 2045, soaring from $1.3235 to an average price of $2.8103, potentially reaching $2.928. While $1.3235 is the low estimate, the potential upside is significant.
- Oncotelic Therapeutics Inc (OTLC) stock is expected to climb by 2050, reaching an average of $1.7874, a $3,371% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.9378 and $1.6371, respectively, highlighting the market's uncertainty.
Oncotelic Therapeutics Inc Stock (OTLC) Year by Year Forecast
Oncotelic Therapeutics Inc Stock (OTLC) Price Forecast for 2025
Oncotelic Therapeutics Inc Stock (OTLC) is expected to reach an average price of $0.2108 in 2025, with a high prediction of $0.324 and a low estimate of $0.0976. This indicates an +309.27% rise from the last recorded price of $0.0515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $0.2087 | $0.2122 | $0.2231 | +305.17% |
| July, 2025 | $0.1674 | $0.1856 | $0.1964 | +225.08% |
| August, 2025 | $0.1387 | $0.1387 | $0.1485 | +169.27% |
| September, 2025 | $0.3251 | $0.1261 | $0.324 | +531.28% |
| October, 2025 | $0.3023 | $0.303 | $0.3135 | +486.93% |
| November, 2025 | $0.2723 | $0.2813 | $0.2908 | +428.68% |
| December, 2025 | $0.232 | $0.2362 | $0.2541 | +350.50% |
Oncotelic Therapeutics Inc Stock (OTLC) Price Forecast for 2026
The predicted value for Oncotelic Therapeutics Inc (OTLC) in 2026 is set at an average of $0.3013. Estimates vary from a peak of $0.448 to a trough of $0.1546, indicating an +485.02% surge from the present price of $0.0515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.1755 | $0.1865 | $0.2216 | +240.85% |
| February, 2026 | $0.1548 | $0.1618 | $0.1652 | +200.52% |
| March, 2026 | $0.3756 | $0.1546 | $0.386 | +629.23% |
| April, 2026 | $0.3355 | $0.3395 | $0.3624 | +551.38% |
| May, 2026 | $0.3034 | $0.3044 | $0.3238 | +489.06% |
| June, 2026 | $0.2448 | $0.263 | $0.2907 | +375.39% |
| July, 2026 | $0.2044 | $0.2045 | $0.223 | +296.95% |
| August, 2026 | $0.4462 | $0.1831 | $0.448 | +766.40% |
| September, 2026 | $0.4117 | $0.4125 | $0.4317 | +699.43% |
| October, 2026 | $0.3701 | $0.3791 | $0.3974 | +618.56% |
| November, 2026 | $0.3152 | $0.3194 | $0.349 | +512.11% |
| December, 2026 | $0.2471 | $0.2581 | $0.3019 | +379.84% |
Oncotelic Therapeutics Inc Stock (OTLC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oncotelic Therapeutics Inc (OTLC) is $0.3918, with a high forecast of $0.572 and a low forecast of $0.2116. This indicates an +660.77% increase from the last price of $0.0515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2147 | $0.2217 | $0.2309 | +316.89% |
| February, 2027 | $0.5059 | $0.2116 | $0.51 | +882.29% |
| March, 2027 | $0.4391 | $0.4431 | $0.4863 | +752.57% |
| April, 2027 | $0.3953 | $0.3963 | $0.4245 | +667.64% |
| May, 2027 | $0.3222 | $0.3404 | $0.3798 | +525.69% |
| June, 2027 | $0.2702 | $0.2702 | $0.2975 | +424.64% |
| July, 2027 | $0.572 | $0.2401 | $0.572 | +1,011% |
| August, 2027 | $0.5211 | $0.5219 | $0.557 | +911.94% |
| September, 2027 | $0.4679 | $0.4769 | $0.5039 | +808.45% |
| October, 2027 | $0.4138 | $0.4187 | $0.4438 | +703.46% |
| November, 2027 | $0.3187 | $0.3297 | $0.3928 | +518.83% |
| December, 2027 | $0.2746 | $0.2816 | $0.2967 | +433.27% |
Oncotelic Therapeutics Inc Stock (OTLC) Price Forecast for 2028
In 2028, Oncotelic Therapeutics Inc (OTLC) is projected to reach an average price of $0.5133, with a high projection of $0.758 and a low estimate of $0.2686. This indicates an +896.72% rise from the last price of $0.0515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6061 | $0.2686 | $0.634 | +1,077% |
| February, 2028 | $0.5427 | $0.5467 | $0.5871 | +953.77% |
| March, 2028 | $0.4873 | $0.4883 | $0.5252 | +846.21% |
| April, 2028 | $0.4369 | $0.4369 | $0.4688 | +748.37% |
| May, 2028 | $0.3359 | $0.336 | $0.3944 | +552.32% |
| June, 2028 | $0.696 | $0.2971 | $0.696 | +1,251% |
| July, 2028 | $0.6306 | $0.6314 | $0.6781 | +1,124% |
| August, 2028 | $0.5656 | $0.5746 | $0.6104 | +998.33% |
| September, 2028 | $0.4999 | $0.5048 | $0.5387 | +870.73% |
| October, 2028 | $0.3903 | $0.4013 | $0.476 | +657.83% |
| November, 2028 | $0.3346 | $0.3416 | $0.3624 | +549.64% |
| December, 2028 | $0.7422 | $0.3256 | $0.758 | +1,341% |
Oncotelic Therapeutics Inc Stock (OTLC) Price Forecast for 2029
The 2029 price forecast for Oncotelic Therapeutics Inc Stock (OTLC) is $0.6181 on average, with a high prediction of $0.882 and a low estimate of $0.3541. This represents an +1,100% increase from the previous price of $0.0515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6463 | $0.6503 | $0.7168 | +1,155% |
| February, 2029 | $0.5793 | $0.5803 | $0.6259 | +1,025% |
| March, 2029 | $0.5172 | $0.5172 | $0.5579 | +904.32% |
| April, 2029 | $0.4017 | $0.4018 | $0.4718 | +680.01% |
| May, 2029 | $0.82 | $0.3541 | $0.82 | +1,492% |
| June, 2029 | $0.7569 | $0.7627 | $0.7992 | +1,370% |
| July, 2029 | $0.6634 | $0.6724 | $0.7338 | +1,188% |
| August, 2029 | $0.5861 | $0.591 | $0.6336 | +1,038% |
| September, 2029 | $0.4902 | $0.5026 | $0.5592 | +851.85% |
| October, 2029 | $0.3945 | $0.4015 | $0.4379 | +666.02% |
| November, 2029 | $0.8604 | $0.3827 | $0.882 | +1,571% |
| December, 2029 | $0.7499 | $0.7539 | $0.8321 | +1,356% |
Oncotelic Therapeutics Inc Stock (OTLC) Price Forecast for 2030
Oncotelic Therapeutics Inc Stock (OTLC) is expected to reach an average price of $0.7086 in 2030, with a high forecast of $1.006 and a low forecast of $0.4112. This signifies an +1,276% surge from the last price of $0.0515.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.6712 | $0.6722 | $0.7266 | +1,203% |
| February, 2030 | $0.5975 | $0.5975 | $0.6469 | +1,060% |
| March, 2030 | $0.4844 | $0.4964 | $0.5492 | +840.50% |
| April, 2030 | $0.944 | $0.4112 | $0.944 | +1,733% |
| May, 2030 | $0.8693 | $0.8751 | $0.9202 | +1,588% |
| June, 2030 | $0.785 | $0.785 | $0.8432 | +1,424% |
| July, 2030 | $0.6722 | $0.6771 | $0.7562 | +1,205% |
| August, 2030 | $0.5647 | $0.5771 | $0.6425 | +996.50% |
| September, 2030 | $0.4544 | $0.4614 | $0.5094 | +782.39% |
| October, 2030 | $0.9786 | $0.4397 | $1.006 | +1,800% |
| November, 2030 | $0.8782 | $0.8872 | $0.9474 | +1,605% |
| December, 2030 | $0.7632 | $0.7642 | $0.8515 | +1,382% |
12.16%
0.06%
Cap:
|
Volume (24h):